Whole cohort | 10 years | 15 years | |
---|---|---|---|
Number alive and eligible for follow-up | 2626 | 723 | 262 |
Completed follow-up, n(%) | 409 (56.7) | 133 (50.8) | |
Number of deaths Cumulative survival, % (95% CI) | 1903 28.9% (27.0% to 30.1%) | 2066 20.6% (19.0% to 22.4%) | |
Number of recurrences Cumulative survival free of recurrence, % (95% CI) | 318 65.3% (61.4% to 68.9%) | 333 54.4% (47.4% to 60.9%) | |
Age at stroke onset, median (IQR) | 73 (62.8–81.2) | 62.1 (52.0–69.7) | 58.1 (48.1–66.4) |
Sex, n (% (95% CI)) | |||
Male | 1299 (49·5 (47.6 to 51.4)) | 425 (58.8 (55.1 to 62.3)) | 159 (60.7 (54.6 to 66.5)) |
Female | 1327 (50.5 (48.6 to 52.4)) | 298 (41.2(37.7 to 44.9)) | 103 (39.3 (33.5 to 45.4)) |
Ethnicity, n (% (95% CI)) | |||
White | 1956 (74.5 (72.8 to 76.1)) | 438 (60.6 (57.0 to 64.1)) | 163 (62.2 (56.1 to 67.9)) |
Black | 473 (18.0 (16.6 to 19.5)) | 214 (29.6 (26.4 to 33.0)) | 77 (29.4 (24.2 to 35.2)) |
Other | 197 (7.5 (6.6 to 8.6)) | 71 (9.8 (7.9 to 12.2)) | 22 (8.4 (5.6 to 12.5)) |
Stroke subtype, n (% (95% CI)) | |||
Ischaemic | 1904 (72.5 (70.8 to 74.2)) | 541 (74.8 (71.5 to 77.9)) | 189 (72·1 (66·4 to 77·3)) |
PICH | 359 (13.7 (12.4 to 15.0)) | 87 (12.0 (9.9 to 14.6) | 34 (13.0 (9.4 to 17.6)) |
SAH | 157 (6.0 (5.1 to 7.0)) | 72 (10.0 (8.0 to 12.4)) | 32 (12.2 (8.7 to 16.8)) |
Unclassified/unknown | 206 (7.8 (6.9 to 8.9)) | 23 (3.2 (2.1 to 47)) | 7 (2.7 (1.3 to 5.5)) |
The health status of stroke survivors was broadly similar at 10 and 15 years: the majority (10 years: 85.1%, 15 years: 86.8%) of participants were living at home and most had some limitation in activities of daily living, with a prevalence of mild-severe disability of 67.0% (62.7% to 71.4%) at 10 years and 63.2% (54.6% to 71.0%) at 15 years.
SAH, subarachnoid haemorrhage; SLSR, South London Stroke Register; PICH, primary intracerebral haemorrhage.